
Richard F Wright MD
Echocardiography, Heart Failure & Transplantation
Chairman, Pacific Heart Institute; Heart failure, Smidt Heart Institute, Cedars-Sinai
Join to view full profile
2001 Santa Monica BlvdSuite 280wSanta Monica, CA 90404
Phone+1 310-829-7678
Fax+1 310-829-6889
Dr. Wright is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1981 - 1984
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1980 - 1981
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1978 - 1979
University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Internal Medicine, 1977 - 1978
Harvard Medical SchoolClass of 1977
Certifications & Licensure
CA State Medical License 1979 - 2026
MA State Medical License 1979 - 1999
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Master American College of Cardiology, 2025
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- Health Care Resource Utilization in Transthyretin Amyloid Cardiomyopathy Compared With Non-amyloid Heart Failure and the General Population.Justin L Grodin, Ahmad Masri, Richard Wright, Jean-François Tamby, Heather Falvey
Journal of the American Heart Association. 2026-08-04 - Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Trial.Amrut V Ambardekar, Nitasha Sarswat, Richard Wright, John Berk, Margot K Davis
Journal of Cardiac Failure. 2026-05-01 - Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial.Prem Soman, Sarah A M Cuddy, Julian D Gillmore, Nitasha Sarswat, Daniel P Judge
JAMA Cardiology. 2026-05-01
Press Mentions
ACC.25: Smidt Heart Institute Experts Present Late-Breaking ResearchMarch 25th, 2025
People with Kidney Disease, Diabetes May Develop Heart Disease 28 Years EarlierNovember 14th, 2024
Diabetes, Kidney Disease Could Raise Cardiovascular Disease Risk up to 28 Years EarlierNovember 11th, 2024
Professional Memberships
- Master
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








